Annual Cash & Cash Equivalents
$53.23 M
-$86.66 M-61.95%
December 31, 2023
Summary
- As of February 7, 2025, COGT annual cash & cash equivalents is $53.23 million, with the most recent change of -$86.66 million (-61.95%) on December 31, 2023.
- During the last 3 years, COGT annual cash & cash equivalents has fallen by -$188.96 million (-78.02%).
- COGT annual cash & cash equivalents is now -78.02% below its all-time high of $242.19 million, reached on December 31, 2020.
Performance
COGT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$97.05 M
+$8.83 M+10.00%
September 30, 2024
Summary
- As of February 7, 2025, COGT quarterly cash and cash equivalents is $97.05 million, with the most recent change of +$8.83 million (+10.00%) on September 30, 2024.
- Over the past year, COGT quarterly cash and cash equivalents has increased by +$8.83 million (+10.00%).
- COGT quarterly cash and cash equivalents is now -70.19% below its all-time high of $325.56 million, reached on June 30, 2022.
Performance
COGT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COGT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.0% | +10.0% |
| 3 y3 years | -78.0% | -52.2% |
| 5 y5 years | -4.4% | +354.7% |
COGT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -70.2% | +82.3% |
| 5 y | 5-year | -78.0% | +42.2% | -70.2% | +354.7% |
| alltime | all time | -78.0% | +88.3% | -70.2% | +354.7% |
Cogent Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $97.05 M(+10.0%) |
| Jun 2024 | - | $88.22 M(-59.1%) |
| Mar 2024 | - | $215.80 M(+305.4%) |
| Dec 2023 | $53.23 M(-61.9%) | $53.23 M(-38.7%) |
| Sep 2023 | - | $86.81 M(-59.5%) |
| Jun 2023 | - | $214.32 M(+33.4%) |
| Mar 2023 | - | $160.70 M(+14.9%) |
| Dec 2022 | $139.89 M(-36.3%) | $139.89 M(-0.5%) |
| Sep 2022 | - | $140.57 M(-56.8%) |
| Jun 2022 | - | $325.56 M(+70.4%) |
| Mar 2022 | - | $191.05 M(-13.0%) |
| Dec 2021 | $219.68 M | $219.68 M(+8.3%) |
| Sep 2021 | - | $202.89 M(-7.0%) |
| Jun 2021 | - | $218.10 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $230.74 M(-4.7%) |
| Dec 2020 | $242.19 M(+547.2%) | $242.19 M(+87.1%) |
| Sep 2020 | - | $129.42 M(+506.4%) |
| Jun 2020 | - | $21.34 M(-27.9%) |
| Mar 2020 | - | $29.60 M(-20.9%) |
| Dec 2019 | $37.42 M(-32.8%) | $37.42 M(-18.4%) |
| Sep 2019 | - | $45.88 M(-17.9%) |
| Jun 2019 | - | $55.86 M(+0.3%) |
| Dec 2018 | $55.67 M(+96.9%) | $55.67 M(+12.9%) |
| Sep 2018 | - | $49.30 M(+5.5%) |
| Jun 2018 | - | $46.73 M(+81.8%) |
| Mar 2018 | - | $25.70 M(-9.1%) |
| Dec 2017 | $28.27 M(-31.6%) | $28.27 M |
| Dec 2016 | $41.32 M | - |
FAQ
- What is Cogent Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cogent Biosciences?
- What is Cogent Biosciences annual cash & cash equivalents year-on-year change?
- What is Cogent Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cogent Biosciences?
- What is Cogent Biosciences quarterly cash and cash equivalents year-on-year change?
What is Cogent Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of COGT is $53.23 M
What is the all time high annual cash & cash equivalents for Cogent Biosciences?
Cogent Biosciences all-time high annual cash & cash equivalents is $242.19 M
What is Cogent Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, COGT annual cash & cash equivalents has changed by -$86.66 M (-61.95%)
What is Cogent Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of COGT is $97.05 M
What is the all time high quarterly cash and cash equivalents for Cogent Biosciences?
Cogent Biosciences all-time high quarterly cash and cash equivalents is $325.56 M
What is Cogent Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, COGT quarterly cash and cash equivalents has changed by +$8.83 M (+10.00%)